Although antipsychotics were developed to treat schizophrenia, newer ones are sometimes used to treat depression that has not been relieved by antidepressants or other treatments. Depression is a ...
But in the case of these drugs, it's a concern because our analysis shows that there is only limited research about the effectiveness and safety of antipsychotics drugs when used for these ...
Nothing arouses the ire of nursing home consumer advocates like the term antipsychotics. A class of medications that was ...
published in the Journal of the American Geriatrics Society. “Antipsychotics are commonly used off-label as first-line agents for pharmacological treatment of behavioral and psychological ...
10mon
The Maine Monitor on MSNUse of antipsychotics in Maine nursing homes climbsAfter an initial crackdown and decline, the rate of the powerful medications given to nursing home residents has ticked back ...
Nottingham knife killer not forced to take long-lasting antipsychotics due to fear of needles, damning report reveals - Shocking report finds another patient being treated by the same trust was arrest ...
We analysed data from 7,216,791 people aged three to 18 years old. In the UK, antipsychotics, also known as “major tranquillisers”, are approved for use in under-18s with psychosis or with severely ...
Some of the most commonly used are antidepressants, anti-anxiety drugs, antipsychotics, mood-stabilizers, and stimulants. Medicines may be an important part of your mental health treatment plan.
Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...
Objective: To review clinical trials and reports describing the efficacy and safety of atypical antipsychotics (olanzapine, ziprasidone, quetiapine, aripiprazole) in the treatment of autistic or ...
Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study published in the Journal of Clinical Psychopharmacology. Maki Gouda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results